Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo - PubMed (original) (raw)
. 1995 Jun;146(6):1309-19.
Affiliations
- PMID: 7778670
- PMCID: PMC1870904
Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo
S Krajewski et al. Am J Pathol. 1995 Jun.
Abstract
The mcl-1 gene encodes an approximately 37-kd protein that has significant homology with Bcl-2, an inhibitor of programmed cell death that is expressed in many types of long-lived cells. In this study we determined the in vivo patterns of Mcl-1 protein production in normal human tissues by immunohistochemical means, using specific polyclonal antisera, and made comparisons with Bcl-2. Like Bcl-2, Mcl-1 immunostaining was observed in epithelial cells in a variety of tissues, including prostate, breast, endometrium, epidermis, stomach, intestine, colon, and respiratory tract. However, often the expression of mcl-1 and bcl-2 in complex epithelia occurred in gradients with opposing directions, such that Bcl-2 immunostaining tended to be higher in the less differentiated cells lining the basement membrane, whereas Mcl-1 immunostaining was more intense in the differentiated cells located in the upper layers of these epithelia. The in vivo patterns of mcl-1 and bcl-2 expression were also strikingly different in several other tissues as well. Within the secondary follicles of lymph nodes and tonsils, for example, germinal center lymphocytes were Mcl-1 positive but mostly lacked Bcl-2; whereas mantle zone lymphocytes expressed bcl-2 but not mcl-1. Intense Mcl-1 immunoreactivity was also detected in several types of neuroendocrine cells, including the adrenal cortical cells that are Bcl-2 negative, sympathetic neurons that also contain Bcl-2, a subpopulation of cells in the pancreatic islets, Leydig cells of the testis, and granulosa lutein cells of the ovarian corpus luteum but not in thyroid epithelium, which is strongly Bcl-2 positive. Little or no Mcl-1 was detected in neurons in the brain and spinal cord, in contrast to Bcl-2, which is present in several types of central nervous system neurons. Conversely, strong Mcl-1 immunostaining was found in cardiac and skeletal muscle, which contain comparatively less Bcl-2. Additional types of cells that are Bcl-2-negative but that expressed mcl-1 include chondrocytes and hepatocytes. These findings demonstrate that mcl-1 expression is widespread in vivo and imply that the Mcl-1 and Bcl-2 proteins fulfill different roles in the overall physiology of cell death regulation.
Similar articles
- Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC. Krajewski S, et al. Am J Pathol. 1994 Sep;145(3):515-25. Am J Pathol. 1994. PMID: 8080035 Free PMC article. - Immunohistochemical analysis of in vivo patterns of Bcl-X expression.
Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed JC. Krajewski S, et al. Cancer Res. 1994 Nov 1;54(21):5501-7. Cancer Res. 1994. PMID: 7923184 - Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.
Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Krajewski S, et al. Am J Pathol. 1994 Dec;145(6):1323-36. Am J Pathol. 1994. PMID: 7992838 Free PMC article. - bcl-2: role in epithelial differentiation and oncogenesis.
Lu QL, Abel P, Foster CS, Lalani EN. Lu QL, et al. Hum Pathol. 1996 Feb;27(2):102-10. doi: 10.1016/s0046-8177(96)90362-7. Hum Pathol. 1996. PMID: 8617450 Review. - Physiological Functions of Mcl-1: Insights From Genetic Mouse Models.
Chin HS, Fu NY. Chin HS, et al. Front Cell Dev Biol. 2021 Jul 16;9:704547. doi: 10.3389/fcell.2021.704547. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34336857 Free PMC article. Review.
Cited by
- Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach.
Hu X, Ye K, Bo S, Xiao Z, Ma M, Pan J, Zhong X, Zhang D, Mo X, Yu X, Chen M, Luo L, Shi C. Hu X, et al. J Transl Med. 2024 Jul 31;22(1):712. doi: 10.1186/s12967-024-05497-w. J Transl Med. 2024. PMID: 39085929 Free PMC article. - Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors.
Cho J, Chung H, Lee S, Kim WH. Cho J, et al. PLoS One. 2024 Jul 16;19(7):e0306398. doi: 10.1371/journal.pone.0306398. eCollection 2024. PLoS One. 2024. PMID: 39012900 Free PMC article. - Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability.
Tantawy SI, Timofeeva N, Hernandez A, Sarkar A, Gandhi V. Tantawy SI, et al. Oncotarget. 2023 Jun 21;14:653-655. doi: 10.18632/oncotarget.28440. Oncotarget. 2023. PMID: 37343064 Free PMC article. No abstract available. - Endogenous and imposed determinants of apoptotic vulnerabilities in cancer.
Sarosiek KA, Wood KC. Sarosiek KA, et al. Trends Cancer. 2023 Feb;9(2):96-110. doi: 10.1016/j.trecan.2022.10.004. Epub 2022 Oct 28. Trends Cancer. 2023. PMID: 37284233 Free PMC article. Review. - Downregulation of miR-125a-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1.
Yu J, Jin Y, Xu C, Fang C, Zhang Z, Chen L, Xu G. Yu J, et al. Mol Biotechnol. 2023 Oct;65(10):1664-1678. doi: 10.1007/s12033-023-00676-4. Epub 2023 Feb 4. Mol Biotechnol. 2023. PMID: 36738360
References
- Am J Pathol. 1994 Dec;145(6):1323-36 - PubMed
- Cancer Res. 1994 Dec 15;54(24):6348-52 - PubMed
- Am J Pathol. 1995 Jan;146(1):20-6 - PubMed
- Mol Cell Biol. 1985 Dec;5(12):3361-8 - PubMed
- Science. 1986 Oct 17;234(4774):364-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources